Form 4 for TBI TrueBlue, Inc.

Accepted 2023-02-02 00:00:00 ET · period of report 2023-01-31 · accession 0000768899-23-000012 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-02-02	2023-01-31	TBI	Gafford Derrek Lane	EVP, CFO	A - Grant	$0.00	+23.9K	108.9K	+28%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-01-31	A	A	8,323	$0.00	117,221	D	—	—	(F2) On February 5, 2021, the Reporting Person was granted Performance Share Units representing an indeterminate number of shares of Issuer's common stock which were contingent upon the meeting of certain individual performance goals, of which up to 50% could be earned based on performance over the 2021-2022 performance period ("Tranche 1") and up to 50% plus any portion of Tranche 1 not previously earned can be earned based on performance over the 2021-2023 performance period. The level of attainment of the performance goals for Tranche 1 was approved on January 31, 2023, resulting in the vesting of the Performance Share Units into shares of the Issuer's common stock on February 5, 2023, pursuant to the terms of the award.
2	Common	Common Stock	2023-01-31	A	A	15,609	$0.00	108,898	D	—	—	(F1) On February 7, 2020, the Reporting Person was granted Performance Share Units representing an indeterminate number of shares of Issuer's common stock which were contingent upon the meeting of certain company performance criteria over the 2020-2022 performance period. The level of attainment of the performance criteria was approved on January 31, 2023, resulting in the vesting of the Performance Share Units into shares of the Issuer's common stock on February 3, 2023.